Correlation of Monoclonal and Polyclonal Somatostatin Receptor (SSTR) 5 Antibodies in Pancreatic Neuroendocrine Tumors

#657

Introduction: For a few years now, highly specific monoclonal antibodies have been available to characterize neuroendocrine tumors for somatostatin-receptor (SSTR) expression.

Aim(s): To evaluate the frequency of somatostatin-receptor 5 in pancreatic neuroendocrine tumors by using monoclonal and polyclonal antibodies.

Materials and methods: We analyzed 66 proven pancreatic neuroendocrine tumors immunohistochemically with monoclonal (clone UMB-4) and polyclonal SSTR 5-antibodies. Immunoreactive score (IRS) and DAKO-score Her2/neu were evaluated.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Peter L

Authors: Kaemmerer D, Lupp A, Peter L, Fischer E, Schulz S,

Keywords: somatostatin, pancreatic tumor, neuroendocrine tumor, monoclonal antibody, UMB-4,

To read the full abstract, please log into your ENETS Member account.